Is There a Need for Positron Emission Tomography Imaging to Stage the N0 Neck in T1-T2 Squamous Cell Carcinoma of the Oral Cavity or Oropharynx?
Authors:
- Markus DietleinMDMarkus Dietlein
- Claus WittekindtCWClaus Wittekindt
- Monika OrtmannMOMonika Ortmann
- Hartmut StuetzerHSHartmut Stuetzer
- Julia VentJVJulia Vent
- Markus JungehuelsingMJMarkus Jungehuelsing
- Barbara KrugBKBarbara Krug
- 1 November 2008
- journal article
- research article
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 117 (11) , 854-863
Abstract
Objectives: We assess whether negative findings on computed tomography (CT), magnetic resonance imaging (MRI), and/or 18 F-fluorodeoxyglucose positron emission tomography ( 18 FDG-PET) may contribute to the decision-making process of elective neck dissection (eND) in patients with squamous cell carcinoma of the oral cavity or the oropharynx (oSCC) staged cT1-T2 cN0 cM0. Methods: We interpreted CT, MRI, and 18 FDG-PET images separately, after combining the data of CT with those of 18 FDG-PET and the data of MRI with those of 18 FDG-PET. Each set of results was then compared with the histopathologic results of ipsilateral or bilateral eND in a prospective, blinded study. Results: The histopathologic examination of 594 lymph nodes revealed 4 metastases less than 4 mm in diameter and 3 micrometastases (less than 2 mm) in 6 of 17 patients. On CT, MRI, and 18 FDG-PET, respectively, 5, 5, and 0 cases were true-malignant (true positives) and 4, 10, and 1 cases were false-malignant (false positives). The accuracy was not enhanced by fusing CT with 18 FDG-PET or MRI with 18 FDG-PET. Conclusions: The detectability threshold of occult metastases appears to be below the spatial and contrast resolution of CT, MRI, and 18 FDG-PET. The decision for eND in patients with cT1-T2 cN0 cM0 oSCC cannot be based upon cross-sectional imaging at the resolutions currently available.Keywords
This publication has 24 references indexed in Scilit:
- Distributions of Cervical Lymph Node Metastases in Oropharyngeal Carcinoma: Therapeutic Implications for the N0 NeckThe Laryngoscope, 2006
- Rational Diagnosis of Squamous Cell Carcinoma of the Head and Neck Region: Comparative Evaluation of CT, MRI, and 18FDG PETAmerican Journal of Roentgenology, 2005
- The Influence of Lymph Node Metastasis in the Treatment of Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, and Hypopharynx: N0 Versus N+The Laryngoscope, 2005
- Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?European Archives of Oto-Rhino-Laryngology, 2003
- Elective Neck Dissection versus Observation in Stage I Squamous Cell Carcinomas of the Tongue and Floor of the MouthOtolaryngology–Head and Neck Surgery, 2001
- Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRIJournal of Cranio-Maxillofacial Surgery, 2000
- T1 and T2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissectionHead & Neck, 1999
- The Incidence of Micrometastases in Neck Dissection Specimens Obtained From Elective Neck DissectionsThe Laryngoscope, 1996
- Floor of Mouth Carcinoma: The Management of the Clinically Negative NeckJAMA Otolaryngology–Head & Neck Surgery, 1995
- Occult lymph node metastasis in small oral tongue cancersHead & Neck, 1992